www.pasithea.com Open in urlscan Pro
95.154.197.180  Public Scan

Form analysis
0 forms found in the DOM

Text Content

Skip to main contentEnable accessibility for visually impairedOpen the
accessibility menu Open the Accessible Navigation Menu






Skip to content

Pasithea

 * Mission
 * Pipeline
 * Leadership
 * Clinics
 * Investors
 * News
 * Contact

Menu
 * Mission
 * Pipeline
 * Leadership
 * Clinics
 * Investors
 * News
 * Contact

 * Mission
 * Pipeline
 * Leadership
 * Clinics
 * Investors
 * News
 * Contact

Menu
 * Mission
 * Pipeline
 * Leadership
 * Clinics
 * Investors
 * News
 * Contact


WE ARE AT THE FOREFRONT OF RESEARCH INTO MENTAL HEALTH
AND BRAIN DISORDERS

Pasithea Therapeutics Corp is a biotech company aiming to solve one of the
world’s biggest clinical problems: brain disorders. The long-term aim is to
translate research into clinic-ready drugs. 




OUR FOCUS




OUR PRIMARY FOCUS IS ON DRUG DEVELOPMENT. THE AIM OF OUR SCIENTIFIC TEAM IS TO
DEVELOP NEW MEDICATIONS THAT PROVIDE BETTER AND LONGER-LASTING RESULTS FOR
INDIVIDUALS WITH MENTAL HEALTH ISSUES.

25 %


THE PERCENTAGE OF THE GLOBAL POPULATION SUFFERING FROM SOME KIND OF MENTAL
HEALTH ISSUE

792 Million


THE NUMBER OF PEOPLE LIVING WITH A MENTAL HEALTH DISORDER


MAJOR DEPRESSION


IS THOUGHT TO BE THE SECOND LEADING CAUSE OF DISABILITY WORLDWIDE

20 Million


THE NUMBER OF PEOPLE ESTIMATED TO BE SUFFERING FROM SCHIZOPHRENIA

3.6 %


THE PERCENTAGE OF PEOPLE GLOBALLY ESTIMATED TO BE SUFFERING FROM PTSD BY THE WHO
(WORLD HEALTH ORGANISATION)

1 in 6 People


EXPERIENCED A MENTAL HEALTH PROBLEM IN THE PAST WEEK

$ 19.2 Billion


THE ESTIMATED SIZE OF THE ANXIETY AND DEPRESSION TREATMENT MARKET BY 2027

$ 16 Trillion


THE ESTIMATED LOSS OF MONEY TO THE GLOBAL ECONOMY DUE TO MENTAL DISORDERS
(PERIOD 2010 – 2030)


OUR CLINICS




THE COMPANY’S SECONDARY OPERATIONS FOCUS ON ESTABLISHING ANTI-DEPRESSION CLINICS
ACROSS THE UK AND USA, USING OUR TRAINED PHARMACISTS TO ADMINISTER INTRAVENOUS
INFUSIONS OF KETAMINE.



US CLINICS

In the USA, Pasithea has partnered with The I.V. Doc®, a leading operator of
mobile clinics, to gain widespread distribution.

UK CLINICS

The UK branch of Pasithea’s clinics is operating from a capital light
partnership with Zen Healthcare, a leading group of practices with three
locations in Marylebone, Holborn and Knightsbridge.


ABOUT US

WORLD CLASS MANAGEMENT TEAM

Pasithea is led by Professor Lawrence Steinman and the research is headed up by
Dr. Tiago Reis Marques.

CAPITAL LIGHT INFRASTRUCTURE

Instant operations in London, Los Angeles and New York City.

DIVERSIFIED REVENUE STREAM

Antidepressant clinics provide greater visibility of revenue & EBITDA.

Learn More

MENU

 * About
 * Pipeline
 * Leadership
 * Clinics
 * Investors
 * News
 * Contact

INVESTORS

 * Press Releases
 * Downloads
 * Corp. Governance
 * Financials

CONTACT

 * info@pasithea.com
 * +1 786-977-3380
 * 1111 Lincoln Road
   Suite 500
   Miami Beach
   FL 33139

SOCIAL MEDIA

Twitter Facebook-f Instagram Linkedin

© Pasithea Therapeutics all rights reserved

Privacy Policy

Terms of use

We use cookies on our website to give you the most relevant experience by
remembering your preferences and repeat visits. By clicking “Accept”, you
consent to the use of ALL the cookies. However you may visit Cookie Settings to
provide a controlled consent.
ACCEPT
Manage consent
Close

PRIVACY OVERVIEW

This website uses cookies to improve your experience while you navigate through
the website. Out of these cookies, the cookies that are categorized as necessary
are stored on your browser as they are essential for the working of basic
functionalities...
Necessary
Necessary
Always Enabled

Necessary cookies are absolutely essential for the website to function properly.
These cookies ensure basic functionalities and security features of the website,
anonymously.

CookieDurationDescriptioncookielawinfo-checbox-analytics11 monthsThis cookie is
set by GDPR Cookie Consent plugin. The cookie is used to store the user consent
for the cookies in the category "Analytics".cookielawinfo-checbox-functional11
monthsThe cookie is set by GDPR cookie consent to record the user consent for
the cookies in the category "Functional".cookielawinfo-checbox-others11
monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to
store the user consent for the cookies in the category
"Other.cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR
Cookie Consent plugin. The cookies is used to store the user consent for the
cookies in the category "Necessary".cookielawinfo-checkbox-performance11
monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to
store the user consent for the cookies in the category
"Performance".viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie
Consent plugin and is used to store whether or not user has consented to the use
of cookies. It does not store any personal data.



Functional
functional

Functional cookies help to perform certain functionalities like sharing the
content of the website on social media platforms, collect feedbacks, and other
third-party features.

Performance
performance

Performance cookies are used to understand and analyze the key performance
indexes of the website which helps in delivering a better user experience for
the visitors.

Analytics
analytics

Analytical cookies are used to understand how visitors interact with the
website. These cookies help provide information on metrics the number of
visitors, bounce rate, traffic source, etc.

Advertisement
advertisement

Advertisement cookies are used to provide visitors with relevant ads and
marketing campaigns. These cookies track visitors across websites and collect
information to provide customized ads.

Others
others

Other uncategorized cookies are those that are being analyzed and have not been
classified into a category as yet.

Save & Accept